A Trotta1, R M Murray1, H L Fisher2. 1. Department of Psychosis Studies,Institute of Psychiatry, Psychology & Neuroscience,King's College London,London,UK. 2. MRC Social, Genetic and Developmental Psychiatry Centre,Institute of Psychiatry, Psychology & Neuroscience,King's College London,London,UK.
Abstract
BACKGROUND: Evidence suggests that childhood adversity is associated with the development of psychotic experiences (PE), psychotic symptoms and disorders. However, less is known regarding the impact of early adversity on the persistence of PE and clinically relevant psychosis. Thus we conducted a systematic review of the association between childhood adversity and the course of PE and symptoms over time. METHOD: A systematic search of Medline, EMBASE and PsychINFO databases was undertaken to identify articles published between January 1956 and November 2014. We included studies conducted on general population samples, individuals at ultra-high risk (UHR) of psychosis, and patients with full-blown psychotic disorders. A meta-analysis was performed on a subgroup. RESULTS: A total of 20 studies were included. Of these, 17 reported positive associations between exposure to overall or specific subtypes of childhood adversity and persistence of PE or clinically relevant psychotic symptoms. A meta-analysis of nine studies yielded a weighted odds ratio of 1.76 [95% confidence interval (CI) 1.19-2.32, p < 0.001] for general population studies and 1.55 (95% CI 0.32-2.77, p = 0.007) for studies conducted using clinical populations. CONCLUSIONS: The available evidence is limited but tentatively suggests that reported exposure to adverse events in childhood is associated with persistence of PE and clinically relevant psychotic symptoms. This partially strengthens the case for addressing the consequences of early adversity in individuals presenting with psychotic phenomena to improve long-term outcomes. However, the heterogeneity of studies was high which urges caution in interpreting the results and highlights the need for more methodologically robust studies.
BACKGROUND: Evidence suggests that childhood adversity is associated with the development of psychotic experiences (PE), psychotic symptoms and disorders. However, less is known regarding the impact of early adversity on the persistence of PE and clinically relevant psychosis. Thus we conducted a systematic review of the association between childhood adversity and the course of PE and symptoms over time. METHOD: A systematic search of Medline, EMBASE and PsychINFO databases was undertaken to identify articles published between January 1956 and November 2014. We included studies conducted on general population samples, individuals at ultra-high risk (UHR) of psychosis, and patients with full-blown psychotic disorders. A meta-analysis was performed on a subgroup. RESULTS: A total of 20 studies were included. Of these, 17 reported positive associations between exposure to overall or specific subtypes of childhood adversity and persistence of PE or clinically relevant psychotic symptoms. A meta-analysis of nine studies yielded a weighted odds ratio of 1.76 [95% confidence interval (CI) 1.19-2.32, p < 0.001] for general population studies and 1.55 (95% CI 0.32-2.77, p = 0.007) for studies conducted using clinical populations. CONCLUSIONS: The available evidence is limited but tentatively suggests that reported exposure to adverse events in childhood is associated with persistence of PE and clinically relevant psychotic symptoms. This partially strengthens the case for addressing the consequences of early adversity in individuals presenting with psychotic phenomena to improve long-term outcomes. However, the heterogeneity of studies was high which urges caution in interpreting the results and highlights the need for more methodologically robust studies.
Authors: Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr Journal: Psychopharmacology (Berl) Date: 2017-02-11 Impact factor: 4.530
Authors: Saliha El Bouhaddani; Lieke van Domburgh; Barbara Schaefer; Theo A H Doreleijers; Wim Veling Journal: Eur Child Adolesc Psychiatry Date: 2019-04-09 Impact factor: 4.785
Authors: J J McGrath; K A McLaughlin; S Saha; S Aguilar-Gaxiola; A Al-Hamzawi; J Alonso; R Bruffaerts; G de Girolamo; P de Jonge; O Esan; S Florescu; O Gureje; J M Haro; C Hu; E G Karam; V Kovess-Masfety; S Lee; J P Lepine; C C W Lim; M E Medina-Mora; Z Mneimneh; B E Pennell; M Piazza; J Posada-Villa; N Sampson; M C Viana; M Xavier; E J Bromet; K S Kendler; R C Kessler Journal: Psychol Med Date: 2017-01-09 Impact factor: 7.723
Authors: Luis Alameda; Philippe Golay; Philipp S Baumann; Pierre Progin; Nadir Mebdouhi; Julien Elowe; Carina Ferrari; Kim Q Do; Philippe Conus Journal: Schizophr Bull Date: 2017-09-01 Impact factor: 9.306
Authors: Raquel E Gur; Tyler M Moore; Adon F G Rosen; Ran Barzilay; David R Roalf; Monica E Calkins; Kosha Ruparel; J Cobb Scott; Laura Almasy; Theodore D Satterthwaite; Russell T Shinohara; Ruben C Gur Journal: JAMA Psychiatry Date: 2019-09-01 Impact factor: 21.596
Authors: Jacqueline Stowkowy; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2016-02-06 Impact factor: 4.328
Authors: John J McGrath; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Jordi Alonso; Laura H Andrade; Evelyn J Bromet; Ronny Bruffaerts; José M Caldas de Almeida; Graça Cardoso; Giovanni de Girolamo; John Fayyad; Silvia Florescu; Oye Gureje; Josep M Haro; Norito Kawakami; Karestan C Koenen; Viviane Kovess-Masfety; Sing Lee; Jean-Pierre Lepine; Katie A McLaughlin; Maria E Medina-Mora; Fernando Navarro-Mateu; Akin Ojagbemi; Jose Posada-Villa; Nancy Sampson; Kate M Scott; Hisateru Tachimori; Margreet Ten Have; Kenneth S Kendler; Ronald C Kessler Journal: Br J Psychiatry Date: 2017-11-02 Impact factor: 9.319